| | The Time Has Come for Physicians to Take Notice: The Impact of Psychosocial Stressors on the HeartAbstract A rapidly growing body of evidence supports a relationship between psychosocial factors and cardiovascular disease. In this article, a review of the epidemiologic and clinical research investigating this relationship concludes that psychosocial stressors can be both a cause and a consequence of cardiovascular disease events. Furthermore, recent data have shown that stress management might reduce future cardiac events in patients with cardiovascular disease. Unfortunately, the influence of psychosocial risk factors on cardiovascular disease remains underrecognized compared with traditional cardiac risk factors. Physicians and their associates should screen for psychosocial stressors and recognize potential symptoms. Consideration should be given to developing improved liaison relationships with psychologic or behavioral specialists to facilitate more specialized interventions when appropriate. A variety of interventions conducted by appropriately trained mental health professionals have successfully improved stress in patients with cardiovascular disease and other chronic diseases. The time has come for physicians to recognize the impact of psychosocial stressors on cardiovascular disease. A growing body of evidence supports a relationship between psychosocial stressors and chronic disease progression. The influence of psychosocial stressors on chronic illnesses remains underrecognized when compared with other risk factors. Chronic disease states, which might be affected by psychosocial factors, include cardiovascular disease, diabetes, cancer, rheumatoid arthritis, human immunodeficiency virus, and chronic obstructive pulmonary disease. Psychologic factors, which have the potential to affect the onset or progression of chronic diseases, include depression, anxiety, anger/hostility, acute and chronic life stressors, and lack of social support. Clinical Significance•Evidence suggests psychosocial risk factors contribute independently to cardiovascular risk, even after controlling for traditional risk factors. •Psychosocial stressors lead to risky health behaviors and might cause changes in the autonomic, endocrine, and inflammatory systems that promote cardiovascular disease. •Patients with cardiovascular disease are best served when their physicians recognize the importance of addressing psychosocial stressors in overall disease management. When appropriate, consultation with a mental health professional should be obtained. The purpose of this article is to review epidemiologic and clinical data investigating the relationship between psychosocial factors and cardiovascular disease, review data suggesting stress management might reduce future cardiac events, and conclude the time has come for physicians to recognize the impact of psychosocial factors on cardiovascular disease. Chronic Psychosocial Factors and Cardiovascular Disease  Data exploring the relationship between psychosocial factors and cardiovascular disease come primarily from epidemiologic studies and prospective studies examining laboratory responses to acute stressors with long-term follow-up of subjects for events. The Harvard Mastery of Stress Study examined the reliability of severe anxiety expressed in laboratory testing as a marker for susceptibility of future cardiovascular disease and other chronic illnesses.1 College students underwent stress experiments, including mental arithmetic with harassment by an experimenter and sonic confusion consisting of hearing one's own voice delayed 0.2 seconds while trying to retell a story from memory as accurately and rapidly as possible under threat of electric shock. After 35 years, the frequency of severe anxiety during testing in college was 59% in those who had developed cardiovascular disease, compared with 27% in healthy subjects. Of note, at the time of publication, there were 6 deaths, 5 of whom had experienced severe anxiety in response to stress experiments carried out in college. INTERHEART studied the association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries.2 In this case-control study, psychosocial stress was assessed by questions assessing stress at work and home, financial stress, major life events in the past year, and presence of depression. Moderate or severe general stress (work, home, or both) had an odds ratio of 1.65 for acute myocardial infarction (adjusted for geographic region, age, sex, and smoking). This increased risk was consistent across regions, ethnic groups, and gender. Permanent general stress had an odds ratio of 2.17 for acute myocardial infarction, 1.33 for severe financial stress, 1.48 for stressful life events, and 1.55 for depression. A meta-analysis of 11 prospective studies of asymptomatic, healthy subjects by Rugulies3 found the presence of clinical depression was associated with major adverse cardiac events (relative risk = 2.69). As a comparison, in the Framingham Heart Study, the presence of hypertension had a relative risk of 1.92 for major adverse cardiac events.4 In the Normative Aging Study, 735 men aged more than 60 years without coronary artery disease were assessed for anxiety characteristics.5 After a 12.4 years, there were 11 myocardial infarctions in the lowest anxiety quartile compared with 29 in the highest quartile. The adjusted relative risk of 1.43 for myocardial infarction was associated with each standard deviation increase in overall anxiety. The impact of low social support, hostility, and anger on the progression of coronary atherosclerosis was studied in 137 subjects with coronary artery disease on baseline coronary angiogram.6 Patients completed self-report questionnaires concerning social support, anger, and hostility. After 2 years, subjects with low social support and high anger expression had an odds ratio of 30 for coronary artery disease progression relative to subjects reporting high social support and low anger. Changes in left ventricular ejection fraction as a function of mental stress testing were examined in 126 patients with coronary artery disease who were subjected to mental tasks during radionuclide ventriculography.7 Those who evidenced mental stress-induced ischemia with a decrease in left ventricular ejection fraction were less likely to remain free of cardiovascular disease events over 5 years (Figure 1). Lesperance et al studied long-term survival after myocardial infarction in relation to the Beck Depression Inventory Score measured during myocardial infarction hospitalization.8 Depression symptoms during myocardial infarction admission were closely linked to long-term survival. Marital Stress and Cardiovascular Disease A longitudinal analysis of 192 couples over 17 years in Tecumseh, Michigan, placed couples into the following categories: both partners communicate their anger, one spouse expresses anger while the other spouse suppresses anger, and both husband and wife suppress their anger and brood.11 In 26 pairs in whom both suppressed their anger, there were 13 deaths: In 27% of couples 1 partner died, and in 23% of couples both partners died. In the remaining 166 pairs (1 or both spouses communicate anger), there were 41 deaths: In 19% of couples 1 partner died, and in 6% of couples both partners died. In the Healthy Women Study, 393 women completed a 7-item measure of relationship quality.12 B-mode carotid ultrasound measured plaque burden after 11 years. Greater plaque burden was found in those who reported low satisfaction with marital quality compared with satisfied wives (Figure 2). Unmarried women were intermediate in plaque burden. Three years later, a subset who reported low marital satisfaction had significant progression to moderate-to-severe levels of plaque burden compared with satisfied women. The authors conclude that high-quality marriages might protect against cardiovascular disease. Further study will hopefully confirm these findings. Acute Stress and Cardiovascular Disease Subjects from the Multicenter Investigation of the Limitation of Infarct Size study were questioned about possible triggers for their myocardial infarction.13 Of 849 subjects, 49% reported a possible trigger; the most common being emotional upset, followed by physical activity, lack of sleep, and overeating. The Northridge earthquake struck Los Angeles on January 17, 1994. The Los Angeles County Coroner reported a sharp increase in cardiovascular disease-related sudden deaths on the day of the earthquake.14 During the previous week, sudden death occurred 4.6 times per day. On the day of the earthquake, there were 24 sudden cardiac deaths. Two hundred New York area patients with implantable cardioverter-defibrillators had their stored electrocardiograms reviewed for ventricular tachyarrhythmias triggering implantable cardioverter-defibrillator therapy before and after the World Trade Center attack of September 11, 2001.15 There was a 2.3-fold increase in ventricular tachyarrhythmias during the month after 9/11, relative to other months between May 2001 and October 2002. An interesting example of the effect of acute emotional stress on the heart is tako-tsubo or transient left ventricular apical ballooning syndrome. Patients present after acute emotional distress with symptoms and electrocardiographic changes consistent with acute myocardial infarction. Left ventriculogram reveals apical ballooning and a hypercontractile basal segment, a shape reminiscent of the pot (tsubo) that Japanese fishermen use to catch octopus (tako). Recent data implicate massive catecholamine release causing stress-induced myocardial stunning. In a study of 22 patients with tako-tsubo syndrome,16 psychologic stressors included death of relative, domestic abuse, arguments, catastrophic medical diagnosis, and devastating financial or gambling losses. In addition to severe emotional upset, catastrophic events have been found to trigger myocardial infarction, earthquakes, missile attacks, and a person's favorite team losing a World Cup football game in a penalty shootout. Carroll et al17 studied myocardial infarction admissions in London after England lost to Argentina in a penalty shootout during the 1998 World Cup. On the day of the match, there was a 25% increase in myocardial infarction admissions compared with the same day in previous years. Increased admissions persisted for 2 days after England's loss, returning to baseline by day 3. Similarly, in a study examining daily cardiovascular disease events in Munich during the 2006 World Cup, cardiovascular emergencies increased 2.7 times in men and 1.8 times in women on the days when Germany was participating in the quarterfinals and semifinals.18 On these days, myocardial infarction and major arrhythmia admissions increased 3 times compared with the same day in previous years (Figure 3). The highest incidence of cardiac events occurred during the first 2 hours of the games. Pathophysiologic Mechanisms of Psychosocial Factors and Cardiovascular Disease Behavioral Mechanisms Psychosocial stressors contribute to a higher frequency of adverse health behaviors; smoking, alcohol binging and abuse, poor dietary compliance, physical inactivity, and poor adherence to medical regimens. Further, psychosocial risk factors and negative behaviors frequently cluster, such as job strain, depression, and poor dietary compliance. This clustering is similar to that seen with more traditional risk factors, such as diabetes and dyslipidemia.19 Pathophysiologic Mechanisms of Chronic Stress In addition to promoting unhealthy behaviors, chronic stressors activate the sympathetic nervous system.20 Repeated sympathetic stimulation increases heart rate and blood pressure.20, 21, 22 Resulting decreased heart rate variability9 and baroreflex dysfunction23 due to autonomic nervous system dysfunction have been associated with increased cardiovascular disease events. Depression increases levels of inflammatory markers, including fibrinogen, C-reactive protein, interleukin-6, and tumor necrosis factor.24, 25, 26, 27 Chronic stressors also activate the hypothalamic-pituitary-adrenal axis producing hypercortisolemia.9 Hypercortisolemia promotes central obesity and insulin resistance, risk factors for cardiovascular disease. However, Whooley et al28 question the importance of pathophysiologic mechanisms mediating the association between depression and cardiovascular disease. In a study of 1017 patients with stable coronary artery disease, the age-adjusted rate of cardiovascular events was 10% among patients with a Patient Health Questionnaire (see American Heart Association Advisory below) score greater than 9 and 6.7% among participants without depressive symptoms. A hazard ratio of 1.31 was reduced to a nonsignificant 1.05 after adjusting for potential behavioral mediators, including physical inactivity, medication nonadherence, and tobacco use. Pathophysiologic Mechanisms of Acute Stress Acute stress activates the sympathetic nervous system. Studies of acute stress testing have demonstrated increases in heart rate and blood pressure, coronary vasoconstriction, and decreased myocardial electrical stability.19 2007 European Guidelines on Cardiovascular Disease Prevention and Clinical Practice The Fourth Joint Task Force of the European Society of Cardiology on Cardiovascular Disease Prevention and Clinical Practice concluded, “there is increasing scientific evidence that psychosocial factors contribute independently to the risk of coronary heart disease, even after statistical control for the effects of standard risk factors.”29 Further, “in addition to increasing the risk of a first event and worsening the prognosis of cardiovascular disease, these factors might act as barriers to treatment adherence and efforts to improve lifestyle.” From a mechanistic standpoint, psychosocial risk factors not only portend to risky health behaviors but also result in pathophysiologic characteristics, such as autonomic, endocrine, and inflammatory changes involved in promoting cardiovascular disease. 2008 American Heart Association Science Advisory on Depression and Coronary Heart Disease Endorsed by the American Psychiatric Association, an American Heart Association Scientific Advisory was recently published, entitled “Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment.”30 This multispecialty consensus document reports that 20% of patients with myocardial infarction meet criteria for major depression, and an even greater number demonstrate elevated depressive symptom levels. Recognizing that, beyond the pathophysiologic effects on the heart, depression is associated with decreased adherence to medications and injurious behaviors, the Advisory proposes an algorithm and Patient Health Questionnaires that healthcare practitioners can use in patients with cardiovascular disease to determine whether depression is present (Figure 4; Table 1, Table 2). They recommend starting with Patient Health Questionnaire-2 (Table 1). If the patient answers yes to either question, then continue with Patient Health Questionnaire-9 (Table 2). Questions are scored not at all = 0; several days = 1; more than half the days = 2; and nearly every day = 3, and then added together to obtain a depression severity score. The Advisory stresses that although there is currently no direct evidence that depression screening leads to improved outcomes in patients with cardiovascular disease, depression is linked with increased cardiovascular disease morbidity and mortality, poorer risk factor modification, and lower medication and cardiac rehabilitation compliance. Treatment options are proposed, including antidepressant pharmacotherapy, cognitive behavioral therapy, and cardiac rehabilitation. The Advisory stresses that patients with positive screening should be evaluated by a mental health professional. Thus, coordination of care between healthcare providers is essential in patients with combined medical and mental health diagnoses.  | Over the past 2 weeks, how often have you been bothered by any of the following problems? |  |  | Little interest or pleasure in doing things. |  |  | Feeling down, depressed, or hopeless. |  | | | |
 | Over the past 2 weeks, how often have you been bothered by any of the following problems? |  |  | Little interest or pleasure in doing things. |  |  | Feeling down, depressed, or hopeless. |  |  | Trouble falling asleep, staying asleep, or sleeping too much. |  |  | Feeling tired or having little energy. |  |  | Poor appetite or overeating. |  |  | Feeling bad about yourself, feeling that you are a failure, or feeling that you have let yourself or your family down. |  |  | Trouble concentrating on things such as reading the newspaper or watching television. |  |  | Moving or speaking so slowly that other people could have noticed. Or being so fidgety or restless that you have been moving around a lot more than usual. |  |  | Thinking that you would be better off dead or that you want to hurt yourself in some way. |  | | | |
Psychosocial and Behavioral Intervention Trials A recent meta-analysis reporting on the psychologic treatment of patients with cardiac disease identified 43 randomized trials, 23 of which reported mortality data for 9856 patients.31 When comparing psychologic treatment plus usual care with usual care alone, the odds ratio is 0.72 for all-cause mortality at 2 years. Mortality benefits only applied to men. However, only 10 studies allowed gender analysis. Psychologic treatment was statistically superior to control for reduction of heart rate and total cholesterol. Psychologic treatment was superior to control in improving both social support and quality of life. In the Myocardial Ischemia Intervention Trial, 107 patients with coronary artery disease with ischemia during mental stress testing or ambulatory electrocardiographic monitoring were randomized to a 4-month program of exercise or stress management.32 Patients living a distance from the facility formed a nonrandom, usual care comparison group. Exercise training consisted of aerobic exercise 3 times per week for 16 weeks. Stress management included sixteen 1.5-hour cognitive behavioral therapy group sessions conducted by a clinical psychologist. Sessions included education, cognitive and behavioral skills training, progressive muscle relaxation, and at least 2 individual biofeedback sessions. Stress management was associated with a lower risk of adverse cardiac events at 5 years compared with usual care (relative risk = 0.26; Figure 5). Exercise was associated with a nonsignificant lowering of cardiac event risk (relative risk = 0.68). Blumenthal et al33 followed this study with a randomized control trial comparing aerobic exercise and stress-management training with routine medical care in 134 patients with stable coronary artery disease with exercise-induced ischemia. Patients in the exercise and stress management groups versus usual care had less depression (Beck Depression Inventory) and reduced distress (General Health Questionnaire). Exercise and stress management groups had smaller reductions in left ventricular ejection fraction during mental stress testing versus usual care. In a subset of patients with significant stress-induced wall motion abnormalities at baseline, exercise and stress management groups had lower wall motion abnormality rating scores and greater improvements in brachial flow-mediated dilation versus usual care. In a subgroup study, patients receiving stress management had improved baroreflex sensitivity and increases in heart rate variability. The authors concluded that exercise and stress management training reduced emotional distress and improved cardiovascular risk markers more than usual medical care in patients with stable coronary artery disease. Milani and Lavie34 compared 522 patients with coronary artery disease who were enrolled in a cardiac rehabilitation program 2000 to 2005 with 179 patients who did not complete rehabilitation. Outpatient cardiac rehabilitation consisted of 12 weeks of 36 educational and exercise sessions. The prevalence of depressive symptoms (Kellner Symptom Questionnaire) decreased 63% after rehabilitation (17% to 6%). After rehabilitation, depressed patients had a significant increased mortality at 3.5 years versus nondepressed patients (22% vs 5%). Depressed patients who completed rehabilitation had a 73% lower mortality compared with control-depressed subjects who did not complete rehabilitation. A reduction in depressive symptoms was related to improvement in fitness, as evidenced by improved peak oxygen consumption during exercise. Not all studies have demonstrated a benefit of cognitive behavioral therapy after myocardial infarction. In the Enhancing Recovery in Coronary Heart Disease Patients trial, 2481 patients post-myocardial infarction were randomized to cognitive behavioral therapy or usual medical care.35 Cognitive behavioral therapy was initiated at a median of 17 days after myocardial infarction for 6 months, plus group therapy when feasible, and selective serotonin reuptake inhibitors for patients scoring higher than 24 on the Hamilton Rating Scale for Depression. The main outcome measure was a composite end point of death or recurrent myocardial infarction. Secondary outcomes included change in the Hamilton Rating Scale for Depression or Enhancing Recovery in Coronary Heart Disease Patients Social Support Instrument scores. Cognitive behavioral therapy did not increase event-free survival. It did improve depression and social isolation scores. Of note, the relative improvement in the psychologic intervention group compared with the usual care group was less than expected because of substantial improvement in the usual care patients. A nonrandomized, post hoc analysis of the Enhancing Recovery in Coronary Heart Disease Patients trial found that patients treated with a selective serotonin reuptake inhibitor, whether assigned to receive cognitive behavioral therapy or usual care, had a 42% reduction in death or recurrent myocardial infarction compared with depressed patients not receiving an selective serotonin reuptake inhibitor.36 The Sertraline AntiDepressant Heart Attack Trial investigation demonstrated that sertraline is safe and efficacious in depressed patients with ischemic heart disease but was underpowered to detect a mortality difference between sertraline and placebo.37 Therefore, although encouraging data suggest intervention can affect patients with coronary artery disease with psychosocial stressors, further study will be required to determine which treatments definitively provide benefit. In addition, future studies prospectively assessing therapies for specific stressors and their ability to decrease events offer the best chance to further elucidate potential pathophysiologic versus behavioral mechanisms underlying this relationship. The Time Has Come for Physicians to Take Notice!  The influence of psychosocial risk factors on cardiovascular disease remains underrecognized compared with traditional cardiac risk factors. Does this mean physicians should act as mental health professionals? No. But given the strong relationship between psychosocial risk factors and cardiovascular disease, physicians need to be proactive participants in their patients' care. Because physicians are accustomed to obtaining medical histories, additional questions about psychosocial risk factors can be incorporated in the review of systems. Conclusions  The recent American Heart Association Science Advisory on Depression in Coronary Heart Disease recommends screening for depression in patients with cardiovascular disease.30 Their proposed algorithm (Figure 4) offers a strategy for assessment and referral of patients with cardiovascular disease with depressive symptoms. Patient Health Questionnaire-2 and Patient Health Questionnaire-9 if needed (Table 1, Table 2) are brief questionnaires for assessing depressive symptoms in patients with cardiovascular disease that can be used during office visits. The Executive Summary of the European Guidelines on Cardiovascular Disease Prevention and Clinical Practice offers tips to help physicians work with their patients with cardiovascular disease to assess potential psychosocial stressors in their life (Table 3).29 One new approach to fostering this more compassionate, identifying relationship between patient and healthcare practitioner is Narrative Medicine, which seeks to improve effectiveness of care by developing the capacity for attention, reflection, representation, and affiliation with patients and colleagues.38 The time has come for physicians to take notice. Encouraging data suggest that intervention can affect patients with coronary artery disease with psychosocial stressors. Further study will be required to determine which treatments definitively provide benefit. In addition to increasing the risk of cardiovascular events and worsening the prognosis of cardiovascular disease, psychosocial factors might act as barriers to treatment adherence and efforts to improve lifestyle.  | Spend enough time with the patient. |  |  | Speak to the patient in his/her own language. |  |  | Develop a sympathetic alliance with the patient. |  |  | Listen carefully and recognize strengths and weaknesses in the patient's attitude to illness and lifestyle change. |  |  | Ensure the patient understands the relationship between lifestyle and disease. |  |  | Accept the patient's personal views of his/her disease and allow expression of worries and anxieties. |  |  | Acknowledge that changing lifelong habits can be difficult and that gradual change that is sustained is often more permanent. |  |  | Gain commitment to lifestyle change. |  |  | Involve the patient in identifying the risk factors to change. |  |  | Explore potential barriers to change. |  |  | Use a combination of strategies, including reinforcement of the patient's own capacity for change. |  |  | Make sure that the patient has understood your advice and has the means to follow it. |  |  | Help design a lifestyle change plan. |  |  | Be realistic and encouraging: “Any increase in exercise is good and can be built on.” |  |  | Reinforce the patient's efforts to change. |  |  | Monitor progress through follow-up contacts; repeated efforts might be required. |  |  | Involve other healthcare staff, wherever possible. |  |  | In patients with manifest cardiovascular disease or very high risk, psychosocial or psychoeducational components should be added to the standard cardiologic care. |  |  | Use a multimodal team approach involving experts and behavioral medicine, mental health, nutrition, and so forth, and expert counseling if barriers to behavioral change become obvious. |  |  | If feasible, intervention programs should be individualized. |  | | | |
References  1. 1Russek LG, King SH, Russek SJ, Russek HI. The Harvard Mastery of Stress Study 35-year follow-up: prognostic significance of patterns of psychophysiological arousal and adaptation. Psychosom Med. 1990;52:271–285. MEDLINE 2. 2Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953–962. Abstract | Full Text |
Full-Text PDF (209 KB)
|
CrossRef
3. 3Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med. 2002;23:51–61. Abstract | Full Text |
Full-Text PDF (158 KB)
|
CrossRef
4. 4Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. MEDLINE 5. 5Shen BJ, Avivi YE, Todaro JF, et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol. 2008;51:113–119. Abstract | Full Text |
Full-Text PDF (437 KB)
|
CrossRef
6. 6Angerer P, Siebert U, Kothny W, et al. Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis. J Am Coll Cardiol. 2000;36:1781–1788. Abstract | Full Text |
Full-Text PDF (188 KB)
|
CrossRef
7. 7Jiang W, Babyak M, Krantz DS, et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA. 1996;275:1651–1656. MEDLINE 8. 8Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049–1053.
CrossRef
9. 9Chandola T, Britton A, Brunner E, et al. Work stress and coronary heart disease: what are the mechanisms?. Eur Heart J. 2008;29:640–648.
CrossRef
10. 10Aboa-Eboule C, Brisson C, Maunsell E, et al. Job strain and risk of acute recurrent coronary heart disease events. JAMA. 2007;298:1652–1660.
CrossRef
11. 11Harburg E, Julius M, Kaciroti N, et al. Expressive/suppressive anger-coping responses, gender, and types of mortality: a 17-year follow-up (Tecumseh, Michigan, 1971-1988). Psychosom Med. 2003;65:588–597.
CrossRef
12. 12Gallo LC, Troxel WM, Kuller LH, et al. Marital status, marital quality, and atherosclerotic burden in postmenopausal women. Psychosom Med. 2003;65:952–962.
CrossRef
13. 13Tofler GH, Stone PH, Maclure M, et al. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990;66:22–27. MEDLINE |
CrossRef
14. 14Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413–419. MEDLINE |
CrossRef
15. 15Steinberg JS, Arshad A, Kowalski M, et al. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J Am Coll Cardiol. 2004;44:1261–1264. Abstract | Full Text |
Full-Text PDF (84 KB)
|
CrossRef
16. 16Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–479.
CrossRef
17. 17Carroll D, Ebrahim S, Tilling K, et al. Admissions for myocardial infarction and World Cup football: database survey. BMJ. 2002;325:1439–1442. 18. 18Wilbert-Lampen U, Leistner D, Greven S, et al. Cardiovascular events during World Cup soccer. N Engl J Med. 2008;358:475–483.
CrossRef
19. 19Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–2217. 20. 20Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 2005;67(Suppl 1):S29–S33.
CrossRef
21. 21Blumenthal JA, Thyrum ET, Siegel WC. Contribution of job strain, job status and marital status to laboratory and ambulatory blood pressure in patients with mild hypertension. J Psychosom Res. 1995;39:133–144. Abstract |
Full-Text PDF (1070 KB)
|
CrossRef
22. 22Steptoe A, Cropley M, Joekes K. Job strain, blood pressure and response to uncontrollable stress. J Hypertens. 1999;17:193–200. MEDLINE 23. 23Thomas KS, Nelesen RA, Ziegler MG, et al. Job strain, ethnicity, and sympathetic nervous system activity. Hypertension. 2004;44:891–896.
CrossRef
24. 24Steptoe A, Kunz-Ebrecht S, Owen N, et al. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med. 2003;65:137–144.
CrossRef
25. 25Ranjit N, Diez-Roux AV, Shea S, et al. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2007;167:174–181. MEDLINE |
CrossRef
26. 26Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol. 2007;50:2044–2050. Abstract | Full Text |
Full-Text PDF (123 KB)
|
CrossRef
27. 27Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immunol. 2002;16:513–524. 28. 28Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–2388.
CrossRef
29. 29Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28:2375–2414.
CrossRef
30. 30Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008;118:1768–1775.
CrossRef
31. 31Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007;28:2972–2984.
CrossRef
32. 32Blumenthal JA, Jiang W, Babyak MA, et al. Stress management and exercise training in cardiac patients with myocardial ischemia (Effects on prognosis and evaluation of mechanisms). Arch Intern Med. 1997;157:2213–2223. MEDLINE 33. 33Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293:1626–1634.
CrossRef
34. 34Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120:799–806. Abstract | Full Text |
Full-Text PDF (304 KB)
|
CrossRef
35. 35Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–3116.
CrossRef
36. 36Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792–798.
CrossRef
37. 37Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709. MEDLINE |
CrossRef
38. 38Charon R. The patient-physician relationship (Narrative medicine: a model for empathy, reflection, profession, and trust). JAMA. 2001;286:1897–1902. MEDLINE |
CrossRef
Einstein Institute for Heart and Vascular Health, Albert Einstein Medical Center, and Jefferson Medical College, Philadelphia, Penn Requests for reprints should be addressed to Vincent M. Figueredo, MD, Einstein Institute for Heart and Vascular Health, 5501 Old York Road, Levy 3, Philadelphia, PA 19141
Conflict of Interest: None. Authorship: Author had access to the data and played a role in writing this manuscript. PII: S0002-9343(09)00402-1 doi:10.1016/j.amjmed.2009.05.001 © 2009 Elsevier Inc. All rights reserved. | |
|